Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection
- PMID: 21742810
- PMCID: PMC4313875
- DOI: 10.1258/ijsa.2011.010551
Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection
Abstract
Herpes simplex virus type 2 (HSV-2) HIV co-infection is common and associated with increased risk of HIV transmission. HSV-2 seroprevalence was assessed on stored samples from baseline and one year follow-up from 81 patients identified with acute HIV infection and 81 age-matched chronically infected men. HSV-2 seroprevalence at baseline was lower for those with acute rather than chronic HIV-infection, 51.9 versus 71.6% (P = 0.01); relative risk 0.72 (95% confidence interval [CI] 0.57-0.92). Since HSV-2 seroprevalence is lower in those newly HIV-infected, the diagnosis of early HIV infection may allow for counselling to reduce subsequent HSV-2 acquisition.
References
-
- Ramaswamy M, Sabin C, McDonald C, et al. Herpes simplex virus type 2 seroprevalence at the time of diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1 infected patients. Sex Transm Dis. 2006;33:96–101. - PubMed
-
- Russell DB, Tabrizi SN, Russell JM, Garland SM. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol. 2001;22:305–313. - PubMed
-
- Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83. - PubMed
-
- Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis. 2005;191:S107–S114. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical